UBS (Lux) Equity Fund - Biotech Q Fonds
272,67
USD
-6,02
USD
-2,16
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,90% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,54% |
| AbbVie Inc | US00287Y1091 | 5,52% |
| Neurocrine Biosciences Inc | US64125C1099 | 5,32% |
| Gilead Sciences Inc | US3755581036 | 5,24% |
| Guardant Health Inc | US40131M1099 | 4,68% |
| Amgen Inc | US0311621009 | 4,32% |
| Royalty Pharma PLC Class A | GB00BMVP7Y09 | 3,28% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 3,19% |
| BioNTech SE ADR | US09075V1026 | 2,98% |
| Sonstige | 49,04% |